Clinical Trial Detail

NCT ID NCT03106987
Title A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer. (OReO)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.